Alfacell sees positive Onconase results |
|
|
|
Published
:
Mon, 16 Apr 2007 20:34
|
BLOOMFIELD, N.J. (AP) - Biotechnology company Alfacell Corp. said Monday preclinical studies of its developing drug Onconase showed it has potential in fighting tumors in non-small cell lung cancer and breast cancer.The drug is already in late-stage clinical development for malignant mesothelioma, a rare form of cancer found in the chest, abdominal cavity lining or the lining around the heart.Shares of Alfacell jumped 41 cents, or 16.9 percent, to $2.91 on the Nasdaq Stock Market in afternoon trading. The stock has traded between 73 cents and $3.94 over the last 52 weeks.Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2630.24 |
+33.88 (
1.30 %)
|
| SYMBOL (
2007-09-28 ) |
| LAST |
CHANGE
|
|
LONMIN
(
11:35am )
|
|
3649.00 |
+251.00 (
7.28 %)
|
|
CARNIVAL
(
11:35am )
|
|
2374.00 |
+157.00 (
7.07 %)
|
|
RIO TINTO
(
11:35am )
|
|
3528.00 |
+65.00 (
1.89 %)
|
| SYMBOL (
2007-09-04 )
|
| LAST |
CHANGE
|
| SYMBOL (
2007-09-04 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Amsterdam shares AFX at a glance outlook 